Skip to content

2018 CLINICAL CONFERENCE at the National Ryan White Conference on HIV Care & Treatment
Evaluation: Monday, December 10, 2018

1. Please indicate your academic degree, license, or position.
2. Please rate each presentation that you attended. If you did not attend or the question is not applicable, leave blank or choose N/A.
DAY 2: MONDAY, DECEMBER 10, 2018
Peter Chin-Hong, MD: Infectious and Other Complications of Immunobiologic Agents Used by Individuals With HIV Infection
Excellent
Very Good
Good
Fair
Poor
N/A
Content
Effectiveness of speaker's teaching methods
Value in fulfilling objectives for this presentation
Value to your practice/responsibility (if applicable)
Freedom from commercial bias or influence
Joseph J. Eron, Jr, MD: Investigational Approaches to Antiretroviral Therapy: New Strategies and Novel Agents
Excellent
Very Good
Good
Fair
Poor
N/A
Content
Effectiveness of speaker's teaching methods
Value in fulfilling objectives for this presentation
Value to your practice/responsibility (if applicable)
Freedom from commercial bias or influence
David L. Thomas, MD, MPH: Elimination of Hepatitis C in Individuals With HIV Infection
Excellent
Very Good
Good
Fair
Poor
N/A
Content
Effectiveness of speaker's teaching methods
Value in fulfilling objectives for this presentation
Value to your practice/responsibility (if applicable)
Freedom from commercial bias or influence
Michael S. Saag, MD: Treating HIV in 2018—Interactive Cases From the Clinic(ians)
Excellent
Very Good
Good
Fair
Poor
N/A
Content
Effectiveness of speaker's teaching methods
Value in fulfilling objectives for this presentation
Value to your practice/responsibility (if applicable)
Freedom from commercial bias or influence
Panelists and Discussion: Treating HIV in 2018—Interactive Cases From the Clinic(ians)
Excellent
Very Good
Good
Fair
Poor
N/A
Value of panel members’ contributions to the discussion
Turner Overton, MD: Cardiovascular Disease Management in HIV Infection
Excellent
Very Good
Good
Fair
Poor
N/A
Content
Effectiveness of speaker's teaching methods
Value in fulfilling objectives for this presentation
Value to your practice/responsibility (if applicable)
Freedom from commercial bias or influence
Raphael J. Landovitz, MD, MSc: Antiretrovirals for HIV Prevention: Optimizing the Use of PrEP and PEP in 2018
Excellent
Very Good
Good
Fair
Poor
N/A
Content
Effectiveness of speaker's teaching methods
Value in fulfilling objectives for this presentation
Value to your practice/responsibility (if applicable)
Freedom from commercial bias or influence
Tami P. Sullivan, PhD: The Intersection of Intimate Partner Violence and HIV: Detection, Disclosure, and Implications for Treatment Adherence
Excellent
Very Good
Good
Fair
Poor
N/A
Content
Effectiveness of speaker's teaching methods
Value in fulfilling objectives for this presentation
Value to your practice/responsibility (if applicable)
Freedom from commercial bias or influence
Donna C. Futterman, MD: Youth and HIV: Are We on Track to End This Epidemic?
Excellent
Very Good
Good
Fair
Poor
N/A
Content
Effectiveness of speaker's teaching methods
Value in fulfilling objectives for this presentation
Value to your practice/responsibility (if applicable)
Freedom from commercial bias or influence
Privacy & Cookie Notice